IP Litigation > Nova Content
Written by Scott R. Seeley and Nathanael Luman, Ph.D.
Old Republic’s IPR petition was effectively unopposed due to a defect in the chain of assignment... Read More »
Written by Nathanael Luman, Ph.D. and Kerry S. Taylor, Ph.D.
The PTAB granted-in-part motions to amend in three related proceedings: Activision Blizzard... Read More »
After Novartis’ patents were found nonobvious by the Fed. Cir., affirming the Delaware District Court, defendant Noven filed for inter partes review (IPR) of... Read More »
Written by Nathanael Luman, Ph.D.
The PTAB weighed five factors in its discretionary denial of a second IPR petition filed by the same petitioner in Xactware... Read More »
Written by Jordan E. Gottdank and Andrea Cheek
The Federal Circuit affirmed-in-part and reversed-in-part the PTAB’s final written decisions on... Read More »
In Novartis AG v. Torrent Pharmaceuticals Limited, [2016-1352] (April 12, 2017), the Federal Circuit affirmed the PTAB’s determination that the challenged... Read More »
Written by Michael Garcia and Andrea Cheek
The Federal Circuit affirmed the PTAB’s final written decisions holding that claims directed to Novartis’s... Read More »
CAFC Emphasizes that Art of Denied Petition Grounds Can Come Back to Haunt Patentees
It is not uncommon for an AIA Trial Proceeding, such as Inter Partes Review... Read More »
Written by Daniel P. Hughes and Karen M. Cassidy
The Federal Circuit affirmed the PTAB’s final written decision holding that claims directed to... Read More »
In a continuing battle between NPE Core Wireless and Apple (in December, Core Wireless won a $7 million verdict in the Northern District of California), the... Read More »
Written by Peter Law and Kerry S. Taylor, Ph.D.
On January 25, 2017, a panel of the Patent Trial and Appeal Board (PTAB) held that “Eleventh Amendment... Read More »
In the first quarter of 2017 we saw a continued decline in patent litigation. The district court litigation was down 26 percent to 1,012, compared to 1,346 in Q4 of... Read More »
PTAB Procedural Reform Initiative
Today the USPTO announced its PTAB Procedural Reform Inititative. The initiative seeks feedback on the nearly five years of... Read More »
Written by Peter Heuser, Schwabe Williamson & Wyatt
The Circuit grants a rehearing and revises its decision in Asetek to vacate the overly broad... Read More »
With its seminal patents and continual patent enforcement activity, hybrid vehicle technology company Paice has been a frequent subject of discussion in this... Read More »
In In re Chudik, [2016-1817] (March 27, 2017), the Federal Circuit reversed the PTAB’s determination that claims 1, 15, 18, and 33–40 of U.S. Patent... Read More »
Written by Daniel A. Kamkar and Nathanael Luman, Ph.D.
The PTAB issued a Final Written Decision in Amerigen Pharm. Ltd. v. Shire LLC, IPR2015-02009, Paper 38... Read More »
Guest Post: SCA v. First Quality
With TC Heartland still on deck a the Supreme Court, a look back at the Court's most recent patent decision SCA v. First... Read More »
Written by Mark E. Davis and Ben J. Everton
Petitioner Unified Patents, LLC filed an IPR petition challenging 29 claims of US Pat. No. 8,640,183 owned by... Read More »
Written by Benjamin Anger and Vikas Bhargava
In a final written decision in Duncan Parking Tech., Inc. v. IPS Group Inc., IPR2016-00067, Paper 29 (P.TA.B. Mar... Read More »